Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 334

1.

Validity of PROMIS physical function measured in diverse clinical samples.

Schalet BD, Hays RD, Jensen SE, Beaumont JL, Fries JF, Cella D.

J Clin Epidemiol. 2016 May;73:112-8. doi: 10.1016/j.jclinepi.2015.08.039. Epub 2016 Mar 9.

PMID:
26970039
2.

PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions.

Cook KF, Jensen SE, Schalet BD, Beaumont JL, Amtmann D, Czajkowski S, Dewalt DA, Fries JF, Pilkonis PA, Reeve BB, Stone AA, Weinfurt KP, Cella D.

J Clin Epidemiol. 2016 May;73:89-102. doi: 10.1016/j.jclinepi.2015.08.038. Epub 2016 Mar 4.

PMID:
26952842
3.

Prednisone Use and Risk of Mortality in Patients With Rheumatoid Arthritis: Moderation by Use of Disease-Modifying Antirheumatic Drugs.

Chester Wasko M, Dasgupta A, Ilse Sears G, Fries JF, Ward MM.

Arthritis Care Res (Hoboken). 2016 May;68(5):706-10. doi: 10.1002/acr.22722.

PMID:
26415107
4.

Establishing a Common Metric for Physical Function: Linking the HAQ-DI and SF-36 PF Subscale to PROMIS(®) Physical Function.

Schalet BD, Revicki DA, Cook KF, Krishnan E, Fries JF, Cella D.

J Gen Intern Med. 2015 Oct;30(10):1517-23. doi: 10.1007/s11606-015-3360-0.

PMID:
25990189
5.

Perspectives from masters in rheumatology and autoimmunity: perspectives on the conventional wisdom.

Fries JF.

Arthritis Rheumatol. 2015 Nov;67(11):2806-12. doi: 10.1002/art.39207. No abstract available.

PMID:
25989060
6.

Do workplace health promotion (wellness) programs work?

Goetzel RZ, Henke RM, Tabrizi M, Pelletier KR, Loeppke R, Ballard DW, Grossmeier J, Anderson DR, Yach D, Kelly RK, McCalister T, Serxner S, Selecky C, Shallenberger LG, Fries JF, Baase C, Isaac F, Crighton KA, Wald P, Exum E, Shurney D, Metz RD.

J Occup Environ Med. 2014 Sep;56(9):927-34. doi: 10.1097/JOM.0000000000000276. Review.

PMID:
25153303
7.

Extending the floor and the ceiling for assessment of physical function.

Fries JF, Lingala B, Siemons L, Glas CA, Cella D, Hussain YN, Bruce B, Krishnan E.

Arthritis Rheumatol. 2014 May;66(5):1378-87. doi: 10.1002/art.38342.

8.

The PROMIS Physical Function item bank was calibrated to a standardized metric and shown to improve measurement efficiency.

Rose M, Bjorner JB, Gandek B, Bruce B, Fries JF, Ware JE Jr.

J Clin Epidemiol. 2014 May;67(5):516-26. doi: 10.1016/j.jclinepi.2013.10.024.

9.

Item response theory, computerized adaptive testing, and PROMIS: assessment of physical function.

Fries JF, Witter J, Rose M, Cella D, Khanna D, Morgan-DeWitt E.

J Rheumatol. 2014 Jan;41(1):153-8. doi: 10.3899/jrheum.130813. Epub 2013 Nov 15.

PMID:
24241485
10.
11.

Upper-extremity and mobility subdomains from the Patient-Reported Outcomes Measurement Information System (PROMIS) adult physical functioning item bank.

Hays RD, Spritzer KL, Amtmann D, Lai JS, Dewitt EM, Rothrock N, Dewalt DA, Riley WT, Fries JF, Krishnan E.

Arch Phys Med Rehabil. 2013 Nov;94(11):2291-6. doi: 10.1016/j.apmr.2013.05.014. Epub 2013 Jun 8.

12.

The theory and practice of active aging.

Fries JF.

Curr Gerontol Geriatr Res. 2012;2012:420637. doi: 10.1155/2012/420637. Epub 2012 Oct 21.

13.

Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis.

Wasko MC, Dasgupta A, Hubert H, Fries JF, Ward MM.

Arthritis Rheum. 2013 Feb;65(2):334-42. doi: 10.1002/art.37723. Erratum in: Arthritis Rheum. 2013 May;65(5):1231.

14.

Osteoarthritis, exercise, and knee replacement.

Fries JF, Bruce B, Shoor S.

J Rheumatol. 2012 Apr;39(4):669-71. doi: 10.3899/jrheum.111087. No abstract available.

PMID:
22467944
15.

Lifestyle risk factors predict disability and death in healthy aging adults.

Chakravarty EF, Hubert HB, Krishnan E, Bruce BB, Lingala VB, Fries JF.

Am J Med. 2012 Feb;125(2):190-7. doi: 10.1016/j.amjmed.2011.08.006.

16.

Disability outcomes and dose escalation with etanercept, adalimumab, and infliximab in rheumatoid arthritis patients: a US-based retrospective comparative effectiveness study.

Schabert VF, Bruce B, Ferrufino CF, Globe DR, Harrison DJ, Lingala B, Fries JF.

Curr Med Res Opin. 2012 Apr;28(4):569-80. doi: 10.1185/03007995.2012.656844. Epub 2012 Mar 6.

PMID:
22236091
17.

Comparative risks of non-prescription analgesics: a structured topic review and research priorities.

Lavonas EJ, Fries JF, Furst DE, Rothman KJ, Stergachis A, Vaida AJ, Zelterman D, Reynolds KM, Green JL, Dart RC.

Expert Opin Drug Saf. 2012 Jan;11(1):33-44. doi: 10.1517/14740338.2012.629782. Epub 2011 Oct 20. Review.

PMID:
22010836
18.

Disability in rheumatoid arthritis in the era of biological treatments.

Krishnan E, Lingala B, Bruce B, Fries JF.

Ann Rheum Dis. 2012 Feb;71(2):213-8. doi: 10.1136/annrheumdis-2011-200354. Epub 2011 Sep 27.

PMID:
21953343
19.

Improved responsiveness and reduced sample size requirements of PROMIS physical function scales with item response theory.

Fries JF, Krishnan E, Rose M, Lingala B, Bruce B.

Arthritis Res Ther. 2011;13(5):R147. doi: 10.1186/ar3461. Epub 2011 Sep 14.

20.

Compression of morbidity 1980-2011: a focused review of paradigms and progress.

Fries JF, Bruce B, Chakravarty E.

J Aging Res. 2011;2011:261702. doi: 10.4061/2011/261702. Epub 2011 Aug 23.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk